Menu
Back to Journals » Biologics: Targets and Therapy
Biologics: Targets and Therapy
ISSN: 1177-5491
- View all (490)
- Volume 17, 2023 (11)
- Volume 16, 2022 (18)
- Volume 15, 2021 (40)
- Volume 14, 2020 (13)
- Volume 13, 2019 (17)
- Volume 12, 2018 (19)
- Volume 11, 2017 (14)
- Volume 10, 2016 (18)
- Volume 9, 2015 (17)
- Volume 8, 2014 (27)
- Volume 7, 2013 (28)
- Volume 6, 2012 (46)
- Volume 5, 2011 (9)
- Volume 4, 2010 (31)
- Volume 3, 2009 (45)
- Volume 2, 2008 (89)
- Volume 1, 2007 (48)
Journal Articles:
- 490 records -
Effectiveness of RCTs Pooling Evidence on Mesenchymal Stem Cell (MSC) Therapeutic Applications During COVID-19 Epidemic: A Systematic Review
Kandula UR, Wake AD
Biologics: Targets and Therapy 2023, 17:85-112
Published Date: 18 May 2023
New Uracil Analog with Exocyclic Methylidene Group Can Reverse Resistance to Taxol in MCF-7 Cancer Cells
Długosz-Pokorska A, Perlikowska R, Janecki T, Janecka A
Biologics: Targets and Therapy 2023, 17:69-83
Published Date: 15 May 2023
Treating Alpelisib-Induced Hyperinsulinemia in Patients with Advanced Breast Cancer – A Real-Life Experience
Percik R, Oedegaard Smith C, Leibovici A, Shai A
Biologics: Targets and Therapy 2023, 17:61-67
Published Date: 3 May 2023
Hypereosinophilic Dermatitis: Successful Treatment with Dupilumab
Wu C, Zhang J, Zhao Y
Biologics: Targets and Therapy 2023, 17:57-60
Published Date: 20 April 2023
Demonstration of Safety in Wild Type Mice of npFOXF1, a Novel Nanoparticle-Based Gene Therapy for Alveolar Capillary Dysplasia with Misaligned Pulmonary Veins
Kohram F, Deng Z, Zhang Y, Reza AA, Li E, Kolesnichenko OA, Shukla S, Ustiyan V, Gomez-Arroyo J, Acharya A, Shi D, Kalinichenko VV, Kenny AP
Biologics: Targets and Therapy 2023, 17:43-55
Published Date: 20 March 2023
Critical Response: “Does the Mutation of Cancer Driver Genes IDH1/2 and CD204 Influence Cancer Metabolism and Tumor Associated Macrophage Recruitment in Tumor Microenvironment” [Letter]
Panjaitan NSD, Handayani S, Dewi RM
Biologics: Targets and Therapy 2023, 17:41-42
Published Date: 20 March 2023
Why and How Should Ethiopia Establish a Stem Cell Transplant Service? A Review Article
Mekonnen S, Farris H
Biologics: Targets and Therapy 2023, 17:33-40
Published Date: 20 March 2023
Elevated Serum Vinculin in Patients with HBV/HCV-Associated Liver Cirrhosis and Hepatocellular Carcinoma: A Pilot Study
Essa A, Essa ES, El-deeb SM, Seleem HEM, Al Sahlawi M, Al-Omair OA, Shehab-Eldeen S
Biologics: Targets and Therapy 2023, 17:23-32
Published Date: 19 March 2023
The Cancer Driver Genes IDH1 and IDH2 and CD204 in WHO-Grade 4 Astrocytoma: Crosstalk Between Cancer Metabolism and Tumour Associated Macrophage Recruitment in Tumour Microenvironment
Kurdi M, Mulla N, Katib Y, Alsinani T, Hakamy S, MJ Addas B, Malibary H, Halawa TF, S Farhan M, Faizo E, Baeesa S
Biologics: Targets and Therapy 2023, 17:15-22
Published Date: 5 February 2023
Preliminary Assessment of Safety and Tolerability of Avacopan During the Early Access Program for ANCA-Associated Vasculitis
van Leeuwen JR, Popov T, Obergfell A, Rabelink TJ, Teng YKO
Biologics: Targets and Therapy 2023, 17:11-14
Published Date: 25 January 2023
Significance of Interleukin 23 in Systemic Lupus Patients: Relation to Disease Activity and Damage Indices
Haroon MM, Hegazy GA, Hassanien MA, Shaker O, Hussein WH
Biologics: Targets and Therapy 2023, 17:1-9
Published Date: 18 January 2023
Adherence to Subcutaneous Anti-Tumour Necrosis Factor Treatment in a Cohort of Patients with Rheumatoid Arthritis Before and After the Implementation of a Comprehensive Care Model
Santos-Moreno P, Sánchez-Vanegas G, Monterrosa-Blanco A, Rodríguez-Vargas GS, Rivero M, Rodriguez P, Calixto OJ, Rojas-Villarraga A, Castro CA
Biologics: Targets and Therapy 2022, 16:199-209
Published Date: 21 November 2022
TNF Inhibitors Exert a “Hidden” Beneficial Effect in the Cardiovascular Lipoprotein Profile of RA Patients
Calvo Alén J, Lavin-Gomez BA, Aurrecoechea E, Guerra Ruiz AR, Martínez Taboada V, Gómez Gerique J
Biologics: Targets and Therapy 2022, 16:187-197
Published Date: 17 October 2022
Phage Therapy: A Different Approach to Fight Bacterial Infections
Hibstu Z, Belew H, Akelew Y, Mengist HM
Biologics: Targets and Therapy 2022, 16:173-186
Published Date: 6 October 2022
Biosimilars: Science, Implications, and Potential Outlooks in the Middle East and Africa
Batran RA, Elmoshneb M, Hussein AS, Hussien OM, Adel F, Elgarhy R, Morsi MI
Biologics: Targets and Therapy 2022, 16:161-171
Published Date: 6 October 2022
Emerging Therapies for Huntington’s Disease – Focus on N-Terminal Huntingtin and Huntingtin Exon 1
van der Bent ML, Evers MM, Vallès A
Biologics: Targets and Therapy 2022, 16:141-160
Published Date: 30 September 2022
A Review on Inflammatory Bowel Diseases: Recent Molecular Pathophysiology Advances
Abdulla M, Mohammed N
Biologics: Targets and Therapy 2022, 16:129-140
Published Date: 12 September 2022
Biologic Therapy for Refractory Immune Checkpoint Inhibitor Colitis
Alorfi NM, Alourfi MM
Biologics: Targets and Therapy 2022, 16:119-127
Published Date: 5 August 2022
Is Tofacitinib Effectiveness in Patients with Rheumatoid Arthritis Better After Conventional Than After Biological Therapy? – A Cohort Study in a Colombian Population
Santos-Moreno P, Martinez S, Ibata L, Villarreal L, Rodríguez-Florido F, Rivero M, Rojas-Villarraga A, Galarza-Maldonado C
Biologics: Targets and Therapy 2022, 16:107-117
Published Date: 13 July 2022
Promising Stem Cell therapy in the Management of HIV and AIDS: A Narrative Review
Kandula UR, Wake AD
Biologics: Targets and Therapy 2022, 16:89-105
Published Date: 8 July 2022
Successful Treatment of an Adult with Atopic Dermatitis and Lamellar Ichthyosis Using Dupilumab
Binkhonain FK, Aldokhayel S, BinJadeed H, Madani A
Biologics: Targets and Therapy 2022, 16:85-88
Published Date: 23 June 2022
Biological Therapies for the Management of Enteric Disease: Considerations for the Clinician
Saleh A, Ansari U, Abughazaleh S, Glassner K, Abraham BP
Biologics: Targets and Therapy 2022, 16:67-83
Published Date: 17 June 2022
Biosimilars in Pediatric IBD: Updated Considerations for Disease Management
Dipasquale V, Cucinotta U, Romano C
Biologics: Targets and Therapy 2022, 16:57-66
Published Date: 13 June 2022
Monoclonal Antibody Therapy for the Treatment of Interstitial Cystitis
Mykoniatis I, Tsiakaras S, Samarinas M, Anastasiadis A, Symeonidis EN, Sountoulides P
Biologics: Targets and Therapy 2022, 16:47-55
Published Date: 20 May 2022
Targeting Metabolic Reprogramming of T-Cells for Enhanced Anti-Tumor Response
Dabi YT, Andualem H, Degechisa ST, Gizaw ST
Biologics: Targets and Therapy 2022, 16:35-45
Published Date: 9 May 2022
Progress in Biological Therapies for Adult-Onset Still’s Disease
Galozzi P, Bindoli S, Doria A, Sfriso P
Biologics: Targets and Therapy 2022, 16:21-34
Published Date: 21 April 2022
Continuous Use of Etanercept During Pregnancy Does Not Affect TNF-Alpha Levels in Umbilical Cord Blood
Nishide M, Yagita M, Kumanogoh A
Biologics: Targets and Therapy 2022, 16:17-19
Published Date: 31 March 2022
A Non-Interventional Multicenter Study of First-Line Bevacizumab in Combination with Chemotherapy in Patients with Metastatic Colorectal Cancer in Lebanon
Temraz S, Nasr F, Kattan J, Abigerges D, Moukadem W, Farhat F, Maatouk L, Chahine G, Shamseddine A
Biologics: Targets and Therapy 2022, 16:7-15
Published Date: 21 February 2022
Efficacy of Anti-Tumor Necrosis Factor-α Therapy Against Intestinal Behçet’s Disease Complicated by Recurrent Enterocutaneous Fistulae
Kashima H, Matsumoto S, Kojima S, Koito Y, Miura T, Ishii T, Mashima H
Biologics: Targets and Therapy 2022, 16:1-6
Published Date: 2 February 2022
Treatment with Ixekizumab Following Secukinumab Failure in Patients with Psoriatic Arthritis: Real-Life Experience from a Resistant Population
Berman J, Furer V, Berman M, Isakov O, Zisman D, Haddad A, Elkayam O
Biologics: Targets and Therapy 2021, 15:463-470
Published Date: 18 November 2021
State-of-the-Art of Monoclonal Antibodies for the Treatment of Gastric Cancer
Basile D, Simionato F, Cappetta A, Garattini SK, Roviello G, Aprile G
Biologics: Targets and Therapy 2021, 15:451-462
Published Date: 3 November 2021
Biological Therapeutic Advances for the Treatment of Advanced Urothelial Cancers
Rizzo M, Giannatempo P, Porta C
Biologics: Targets and Therapy 2021, 15:441-450
Published Date: 1 November 2021
Certolizumab Can Also Be Effective in Monotherapy for the Treatment of Rheumatoid Arthritis Patients
Santos-Moreno P, Martinez S, Ibatá L, Villarreal L, Rivero M, Rojas-Villarraga A
Biologics: Targets and Therapy 2021, 15:433-440
Published Date: 22 October 2021
Emerging Monoclonal Antibody Therapy for the Treatment of Acute Lymphoblastic Leukemia
Abuasab T, Rowe J, Tvito A
Biologics: Targets and Therapy 2021, 15:419-431
Published Date: 18 October 2021
Immunotherapeutic Advances for NSCLC
Massafra M, Passalacqua MI, Gebbia V, Macrì P, Lazzari C, Gregorc V, Buda C, Altavilla G, Santarpia M
Biologics: Targets and Therapy 2021, 15:399-417
Published Date: 8 October 2021
Stem Cell Therapy for Burns: Story so Far
Abdul Kareem N, Aijaz A, Jeschke MG
Biologics: Targets and Therapy 2021, 15:379-397
Published Date: 31 August 2021
Adalimumab Therapy in a Patient with Psoriasis, Down Syndrome, and Concomitant Hepatitis B Virus Infection
Madani A, Almuhaideb Q
Biologics: Targets and Therapy 2021, 15:375-378
Published Date: 1 September 2021
An Overview of the Safety and Efficacy of Monoclonal Antibodies for the Chronic Obstructive Pulmonary Disease
Cazzola M, Ora J, Cavalli F, Rogliani P, Matera MG
Biologics: Targets and Therapy 2021, 15:363-374
Published Date: 27 August 2021
Mechanism and Applications of CRISPR/Cas-9-Mediated Genome Editing
Mengstie MA, Wondimu BZ
Biologics: Targets and Therapy 2021, 15:353-361
Published Date: 21 August 2021
Biological Therapies for Rheumatoid Arthritis: An Overview for the Clinician
Findeisen KE, Sewell J, Ostor AJK
Biologics: Targets and Therapy 2021, 15:343-352
Published Date: 12 August 2021
HHLA2 Expression is Associated with Poor Survival in Patients with Hepatocellular Carcinoma
Xu Y, Zhijie H, Yu X, Li Z, Zheng L, Xu J
Biologics: Targets and Therapy 2021, 15:329-341
Published Date: 13 August 2021
Infliximab in Combination with Low-Dose Acitretin in Generalized Pustular Psoriasis: A Report of Two Cases and Review of the Literature
Kołt-Kamińska M, Żychowska M, Reich A
Biologics: Targets and Therapy 2021, 15:317-327
Published Date: 7 August 2021
View Point: Disease Modification and Cell Secretome Based Approaches in Parkinson’s Disease: Are We on the Right Track?
Müller T
Biologics: Targets and Therapy 2021, 15:307-316
Published Date: 29 July 2021
Stem Cell Therapy for Retinal Degeneration: The Evidence to Date
Sharma A, Jaganathan BG
Biologics: Targets and Therapy 2021, 15:299-306
Published Date: 27 July 2021
Sensitivity Assessment of Wilms Tumor Gene (WT1) Expression in Glioblastoma using qPCR and Immunohistochemistry and its Association with IDH1 Mutation and Recurrence Interval
Kurdi M, Butt NS, Baeesa S, Kuerban A, Maghrabi Y, Bardeesi A, Saeedi R, Alghamdi BS, Lary AI, Mohamed F, Hakamy S
Biologics: Targets and Therapy 2021, 15:289-297
Published Date: 24 July 2021
High Body Mass Index is Associated with Shorter Retention of Tumor Necrosis Factor-Alpha Blocker Treatment in Rheumatoid Arthritis
Elalouf O, Lidar M, Reitblat T, Zisman D, Balbir-Gurman A, Hakakian O, Mashiach T, Almog R, Elkayam O
Biologics: Targets and Therapy 2021, 15:279-287
Published Date: 20 July 2021
The Impact of NK Cell-Based Therapeutics for the Treatment of Lung Cancer for Biologics: Targets and Therapy
Hamilton G, Plangger A
Biologics: Targets and Therapy 2021, 15:265-277
Published Date: 7 July 2021
Using Monoclonal Antibody Therapies for Multiple Sclerosis: A Review
Elsbernd PM, Carter JL
Biologics: Targets and Therapy 2021, 15:255-263
Published Date: 30 June 2021
Latest Advances for the Treatment of Chronic Plaque Psoriasis with Biologics and Oral Small Molecules
Bellinato F, Gisondi P, Girolomoni G
Biologics: Targets and Therapy 2021, 15:247-253
Published Date: 29 June 2021
An Australian Real-World Study of Treatment Persistence of Ustekinumab in Crohn’s Disease
Chien TH, Puig A, Khuong T, Kouhkamari MH, Che S, Huang THW
Biologics: Targets and Therapy 2021, 15:237-245
Published Date: 16 June 2021